|
2025
|
Invention
|
Antibodies and vaccines having vh3-21 and vl1-40 binding domains and uses thereof. An antibody ag... |
|
|
Invention
|
Novel tcrs and neoantigens in srsf2 and zrsr2 mutated cancers. SRSF2ZRSR2ZRSR2, wherein the mutat... |
|
|
Invention
|
Sclcpheno-seq, a targeted capture panel and associated methodology to call the activity of key tr... |
|
|
Invention
|
Gene editing for latent herpes simplex virus infection reduces viral load and shedding in vivo. E... |
|
|
Invention
|
Vaccines and compositions against gamma herpesviruses. The disclosure provides compositions, meth... |
|
|
Invention
|
Compositions and methods to modify cells for therapeutic objectives.
The present disclosure prov... |
|
|
Invention
|
Engineered nanoparticles for targeted internalization by human blood cells. Engineered nanopartic... |
|
|
Invention
|
Machine learning model for rapidly predicting cell segmentation of spatial transcriptomic cell da... |
|
|
Invention
|
Cell-free implants for in vivo recruitment, activation, and reprogramming of immune cells. in viv... |
|
|
Invention
|
Methods for the treatment of b cell malignancies using adoptive cell therapy.
Provided are adopt... |
|
2024
|
Invention
|
Newborn screening for primary immunodeficiencies, cystinosis, and wilson disease.
Newborn screen... |
|
|
Invention
|
Immunization schedules to elicit broadly-neutralizing antibodies against human immmunodeficiency ... |
|
|
Invention
|
Combination of a cell therapy and a gamma secretase inhibitor.
Provided herein are combination t... |
|
|
Invention
|
Binding proteins and engineered cells specific for neoantigens and uses thereof.
The present dis... |
|
|
Invention
|
Gas-bubble based degrading liquid foams to deliver nucleic acids. Gas-bubble based degrading liqu... |
|
|
Invention
|
Binding proteins specific for ras neoantigens and uses thereof.
The present disclosure provides ... |
|
|
Invention
|
Compositions and methods for cellular immunotherapy. e.g.e.g. e.g. T) cell signaling properties. ... |
|
|
Invention
|
Devices and methods involving analysis of patient data based on nucleic acid sequence analysis. I... |
|
|
Invention
|
Clec2a-binding therapeutics. ex vivoin vivoin vivo for research, diagnostic, or therapeutic purpo... |
|
|
Invention
|
Methods and compositions for improving t cell immunotherapy. e.g.e.g., CD8+ T cells, CD4+ T cells... |
|
|
Invention
|
Anti-cd33 antibodies and uses thereof.
Anti-CD33 antibodies are described. The anti-CD33 antibod... |
|
|
Invention
|
Proteins bispecific to cd3 and nkg2dl and associated uses thereof. The present technology provide... |
|
|
Invention
|
Dna hypomethylation as a predictive marker for cancer therapy.
DNA hypomethylation as a predicti... |
|
|
Invention
|
Anti-cd90 antibodies, binding fragments, and uses thereof. ex vivoin vivoin vivo for a research, ... |
|
|
Invention
|
Compositions and methods for providing hematopoietic function.
The present invention relates to ... |
|
|
Invention
|
Epigentic regulation and co-targeting approaches of psma in prostrate cancer.
Provided herein ar... |
|
|
Invention
|
Compositions and methods for the treatment of diseases with isocitrate dehydrogenase 1/2 mutation... |
|
|
Invention
|
Siglec-8 antibodies and uses thereof.
Siglec-8 antibodies and uses thereof are described. The Si... |
|
|
Invention
|
Systems and methods for mobile-enabled targeted nanopore sequencing with mobile-enabled real-time... |
|
|
Invention
|
Treating alphaherpesvirus infections using gene drive technology. Provided are genetically modifi... |
|
|
Invention
|
Methods and compositions for inhibiting the growth and/or proliferation of myc-driven tumor cells... |
|
|
Invention
|
Immunomodulatory fusion proteins and uses thereof.
Described herein are immunomodulatory fusion ... |
|
|
G/S
|
Association services for promoting the public interest and awareness in cancer research and educa... |
|
|
G/S
|
Reagents and monoclonal antibodies for in vitro scientific or research use.
Diagnostic reagents a... |
|
|
G/S
|
Reagents and monoclonal antibodies for in vitro scientific
or research use. Diagnostic reagents ... |
|
2023
|
G/S
|
Apparel, namely, t-shirts, polo shirts, tank tops, long
sleeve shirts; athletic apparel, namely,... |
|
|
G/S
|
Apparel, namely, t-shits, polo shirts, tank tops, long sleeve shirts; athletic apparel, namely, s... |
|
|
G/S
|
Apparel, namely, t-shits, polo shirts, tank tops, long
sleeve shirts; athletic apparel, namely, ... |
|
|
G/S
|
Downloadable electronic publications in the nature of newsletters, pamphlets, brochures, magazine... |
|
|
Invention
|
Antibodies with novel fc modification combinations that increase antibody function.
Antibodies w... |
|
|
G/S
|
Apparel, namely, t-shirts, polo shirts, tank tops, long sleeve shirts; athletic apparel, namely, ... |
|
|
Invention
|
Humanized anti-cd45 antibodies and uses thereof.
Novel chimeric and/or humanized forms of the an... |
|
|
Invention
|
Profiling rna at chromatin targets in situ by antibody-targeted tagmentation.
Embodiments of the... |
|
|
Invention
|
Anti-cd90 antibodies, binding fragments, and uses thereof.
Anti-CD90 antibodies, binding fragmen... |
|
|
Invention
|
Dna methylation biomarkers for detection of high-grade dysplasia and esophageal or junctional ade... |
|
|
Invention
|
Human t cell receptor pairs reactive with hla-a*02:01 restricted human prostatic acid phosphatase... |
|
|
Invention
|
Machine learning applications to predict biological outcomes and elucidate underlying biological ... |
|
|
Invention
|
Cd4+ t cell markers, compositions, and methods for cancer.
The present disclosure relates, in pa... |
|
|
Invention
|
Chimeric antigen receptors binding steap1.
Chimeric antigen receptor (CAR) with a binding domain... |
|
|
Invention
|
Inhibitor-resistant mgmt modifications and modification of mgmt-encoding nucleic acids.
The pres... |
|
2022
|
Invention
|
Methods and compositions for modulating the myeloid arm of the immune system.
Methods and compos... |
|
|
Invention
|
Treatments for cancers utilizing cell-targeted therapies and associated research protocols.
Targ... |
|
|
Invention
|
T cell immunotherapy for hematologic malignancies having an sf3b1 mutation.
Provided are composi... |
|
|
G/S
|
Reagents and monoclonal antibodies for in vitro scientific or research use Downloadable electroni... |
|
|
Invention
|
Chimeric transmembrane polypeptides comprising a tgf beta receptor extracellular domain, a transm... |
|
|
Invention
|
Method for analyzing the ability of target nucleic acid sequences to impact gene expression.
A m... |
|
|
G/S
|
Reagents and monoclonal antibodies for in vitro scientific or research use Diagnostic reagents an... |
|
2021
|
Invention
|
Compositions and methods for cellular immunotherapy.
The present application concerns chimeric c... |
|
|
Invention
|
Compositions and methods for selective depletion of target molecules.
Described herein are compo... |
|
2014
|
G/S
|
Printed publications, namely, newsletters, pamphlets, brochures, magazines, instruction sheets an... |
|
2012
|
G/S
|
Promoting public awareness about cancer and cancer research Charitable fund raising Organization ... |
